advertisement
Hommer A 9
Showing records 1 to 9 | Display all abstracts from Hommer A66745 Comparison of preservative-free latanoprost and preservative-free bimatoprost in a multicenter, randomized, investigator-masked cross-over clinical trial, the SPORT trial
Stalmans I
Graefe's Archive for Clinical and Experimental Ophthalmology 2016; 254: 1151-1158
67517 A combined analysis of four observational studies evaluating the intraocular pressure-lowering ability and tolerability of bimatoprost 0.01% in patients with primary open-angle glaucoma or ocular hypertension
Stevens A
Clinical Ophthalmology 2016; 10: 635-641
66745 Comparison of preservative-free latanoprost and preservative-free bimatoprost in a multicenter, randomized, investigator-masked cross-over clinical trial, the SPORT trial
Oddone F
Graefe's Archive for Clinical and Experimental Ophthalmology 2016; 254: 1151-1158
67517 A combined analysis of four observational studies evaluating the intraocular pressure-lowering ability and tolerability of bimatoprost 0.01% in patients with primary open-angle glaucoma or ocular hypertension
Iliev ME; de Jong L
Clinical Ophthalmology 2016; 10: 635-641
66745 Comparison of preservative-free latanoprost and preservative-free bimatoprost in a multicenter, randomized, investigator-masked cross-over clinical trial, the SPORT trial
Cordeiro MF
Graefe's Archive for Clinical and Experimental Ophthalmology 2016; 254: 1151-1158
67517 A combined analysis of four observational studies evaluating the intraocular pressure-lowering ability and tolerability of bimatoprost 0.01% in patients with primary open-angle glaucoma or ocular hypertension
Grobeiu I
Clinical Ophthalmology 2016; 10: 635-641
66745 Comparison of preservative-free latanoprost and preservative-free bimatoprost in a multicenter, randomized, investigator-masked cross-over clinical trial, the SPORT trial
Hommer A; Montesano G
Graefe's Archive for Clinical and Experimental Ophthalmology 2016; 254: 1151-1158
67517 A combined analysis of four observational studies evaluating the intraocular pressure-lowering ability and tolerability of bimatoprost 0.01% in patients with primary open-angle glaucoma or ocular hypertension
Hommer A
Clinical Ophthalmology 2016; 10: 635-641
66745 Comparison of preservative-free latanoprost and preservative-free bimatoprost in a multicenter, randomized, investigator-masked cross-over clinical trial, the SPORT trial
Ribeiro L; Sunaric-Mégevand G; Rossetti L
Graefe's Archive for Clinical and Experimental Ophthalmology 2016; 254: 1151-1158
